This may seem like a simple question, but when you consider the factors that impact data quality, it is quite complex. Not unlike other businesses, pharma relies on a rich flow of data for making and assessing strategic decisions. For pharma, data comes from many different sources. The ability to capture patient data from multiple disparate sources, such as SP and HUB data, and integrate it...
Read More
The future of medicine is being driven by technology as a part of scientific discovery. Precision medicine, an emerging treatment paradigm, aims to find the right therapy at the right time based on an individual's unique genetic background,. Studies of phenotypes and genotypes, along with the use of Artificial Intelligence (AI), have provided vast and expanding knowledge of how genomics play a role in determining...
Read More
Imagine that your company is preparing to launch a new branded drug with distinct advantages in efficacy and side-effect profile. You are challenged by a crowded market dominated by generics. Ninety-six percent of the market share is shared across multiple generics; three other branded products compete for the remaining 4%. The market value is high, so dominating the branded competitors is not only a significant...
Read More
When selecting a partner for the de-identification, integration, and management of patient data — while securing patient privacy — it's important to ensure the use of the right technologies and processes. It's equally as important to weigh the value of all the additional benefits (service, flexibility, etc.) a potential partner provides. Providing best-in-class de-identification and matching capabilities, MSA offers the most credentialed, most configurable, and most trusted data management solutions,...
Read More
Over the past decade, the distribution model for medication delivery has evolved from retail pharmacies and mail order to Specialty Pharmacies (SP), 340B Contract Pharmacies, and Rare Disease Pharmacies. In addition, large health systems are continuing the trend of market consolidation by purchasing physician practices, smaller regional hospitals, long-term care facilities and other ancillary healthcare services. These health systems are using their size and influence...
Read More
Pharma is facing the many challenges of COVID-19 head-on. Leading organizations are taking full advantage of today’s sophisticated analytic tools, including state-of-the-art anonymization technologies that seamlessly link patient data across multiple sources, to monitor the impact of COVID-19 on treatments in new ways. Since the COVID-19 pandemic began, the industry has been primarily focused on understanding the journey of severely ill, older adults requiring hospitalization. More...
Read More
Did you know that 70% of medical diagnosis are informed by clinical lab results data? Over the past five months, round-the-clock news reports have kept us well informed of data related to patients testing positive for COVID-19. People everywhere have been closely following this data in an attempt to gauge – and hopefully control – the impact of the virus. Critical insights about the patient journey can,...
Read More
MSA’s Healthcare Data Management experts provide solutions that empower pharma to better understand the impact of COVID-19 on the diabetes patient journey by linking clinical lab results, prescriptions, EMR, and medical claims data – all while protecting patient privacy. MSA, provider of the industry’s most credentialed, configurable, and trusted de-identification and data management solutions, accurately anonymizes and seamlessly links disparate data from one or multiple...
Read More
A close examination of the COVID-19 patient journey will result in a better understanding of the impact of the virus on at-risk diabetes patients. Segmenting positive and negative COVID-19 patients provides a real world comparison of anonymized patient cohorts’ A1C, fasting blood sugars, and glucose levels. Linked with prescribed medications, this data will identify the impact of COVID-19 on the patients’ prescribed drug therapy. The...
Read More
Patient-level data matching, a fundamental and critical success factor for the longitudinal alignment of anonymized health information, can be a daunting challenge given the complexity, sensitivity, volume, and heterogeneity of patient healthcare data, as well as the use of primitive technologies. A comprehensive picture of the anonymized patient requires accurate matching of individual patients to their health records across settings, however, patient matching rates vary widely. Matching records to the correct anonymized...
Read More
Patient privacy and data security are among the most pressing issues facing organizations trying to bring healthcare data together. Aligning data across the full patient journey is complicated by the fact that healthcare data in both clinical care and the “real world” is generated in many forms. Committed to advancing healthcare while protecting Personal Health Information (PHI), MSA supports compliance with standards, guidelines, and legislation issued by regulatory bodies,...
Read MoreMSA is thrilled to be heading to the Specialty Pharmacy Summit 2019 presented by Asembia, April 29 through May 2, in Las Vegas. Tony Fontecchio, VP, and Linda Vetovich will meet with SP industry leaders to explain how the Life Sciences division applies the corporate competencies (data management, business analytics, and information technology) to healthcare data management and to healthcare data infusion and analytics. Utilizing patented...
Read More